News und Analysen
Philip Morris International to Present at 2025 CAGNY Conference
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial
Eastman CEO Mark Costa to Address the Barclays Industrial Select Conference
Eastman Chemical Company (NYSE:EMN):
Industrial Select Conference
Mark Costa, Board Chair and Chief Executive Officer, Eastman Chemical Company (NYSE:EMN), will address the Barclays 42nd
Union Pacific Corporation Executives to Address Barclays 2025 Industrial Select Conference
Jim Vena, chief executive officer, Jennifer Hamann, executive vice president and chief financial officer, and Kenny Rocker, executive vice president – Marketing & Sales, of Union Pacific
ServiceNow Launches Government Transformation Suite, Uniting High-Impact Solutions Tailored to Administration Priorities
SERVICENOW FEDERAL FORUM – ServiceNow (NYSE: NOW), the AI platform for business transformation, today launched the new Government Transformation Suite to increase visibility, accelerate ROI, and
Exelon Reports Fourth Quarter and Full Year 2024 Results and Initiates 2025 Financial Outlook
Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024.
"I am pleased to announce Exelon has delivered against our financial goals for
Exelon Reports Fourth Quarter and Full Year 2024 Results and Initiates 2025 Financial Outlook
Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024.
"I am pleased to announce Exelon has delivered against our financial goals for
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edison International
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edison International (“Edison” or the “Company”) (NYSE: EIX) and reminds investors of the
AIG Reports Outstanding Fourth Quarter and Full Year 2024 Results
American International Group, Inc. (NYSE: AIG) today reported financial results for the fourth quarter and full year ended December 31, 2024.
“2024 was an outstanding year of accomplishments for
Keysight Joins Forces with the EU to Drive Innovation in 6G
Keysight Technologies, Inc. (NYSE: KEYS) is enhancing Europe’s 6G research and innovation landscape by participating in two projects that are a part of the 6G Smart Networks and Services Joint
Williams Und Atlassian Kündigen Titelpartnerschaft an Und Formen Atlassian Williams Racing
Williams Racing und Atlassian geben eine neue, langfristige Titelpartnerschaft bekannt, die eine neue Ära für das ikonische Formel-1-Team als Atlassian Williams Racing einleiten wird.
Williams
Williams Und Atlassian Kündigen Titelpartnerschaft an Und Formen Atlassian Williams Racing
Williams Racing und Atlassian geben eine neue, langfristige Titelpartnerschaft bekannt, die eine neue Ära für das ikonische Formel-1-Team als Atlassian Williams Racing einleiten wird.
Williams
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Williams and Atlassian Announce Title Partnership to Form Atlassian Williams Racing
Williams Racing and Atlassian are thrilled to announce a long-term title partnership that will usher in a new era for the iconic Formula 1 team as Atlassian Williams Racing.
Williams, the
Williams and Atlassian Announce Title Partnership to Form Atlassian Williams Racing
Williams Racing and Atlassian are thrilled to announce a long-term title partnership that will usher in a new era for the iconic Formula 1 team as Atlassian Williams Racing.
Williams, the
Howmet Aerospace to Present at Barclays 2025 Industrial Select Conference
Howmet Aerospace Inc. (NYSE:HWM) announced today that John C. Plant, Chairman and Chief Executive Officer, and Ken Giacobbe, Executive Vice President and Chief Financial Officer, will speak at the
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3 EV-302 clinical trial (also
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced additional follow-up results from the Phase 3 EV-302 clinical trial (also
AIG to Host Investor Day on March 31, 2025
American International Group, Inc. (NYSE: AIG) will host an Investor Day on Monday, March 31, 2025, beginning at 8:30 a.m. ET.
A live webcast of the presentation and associated materials will be
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Board of Directors of Sartorius Stedim Biotech resolves to propose dividend of 0.69 euros per share to Annual Shareholders’ Meeting
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Trane Technologies to Present at the Citi Global Industrial Tech and Mobility Conference
Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate in a fireside chat at the Citi Global Industrial Tech and Mobility Conference
Trane Technologies to Present at the Barclays Industrial Select Conference
Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate in a fireside chat at the Barclays Industrial Select Conference. They will
State Street Corporation Announces Issuance of Preferred Stock
State Street Corporation (“State Street”) (NYSE: STT) announced today that it has issued $750 million of depositary shares, each representing a 1/100th ownership interest in a share of its 6.450%
Essex Property Trust Prices $400 Million of Senior Notes
Essex Property Trust, Inc. (NYSE:ESS) (“Essex”) announced today that its operating partnership, Essex Portfolio, L.P. (the “Issuer”), priced an underwritten public offering of $400 million




